Sanofi India Limited (SIL) today announced that Rodolfo Hrosz has been appointed as the Company’s new Managing Director, effective June 1, 2022, subject to regulatory approvals. As soon as the necessary regulatory clearances are in place, he will transition from Sanofi’s General Manager, Consumer Healthcare division in Brazil to his new job in India.
Rodolpho joined Sanofi as General Manager of the Consumer Healthcare business in Brazil in 2017 and has guided the company through numerous transformational stages, from its conception to becoming a top growth contributor and a digital-acceleration reference point within the Sanofi Group.
Rodolfo brings a lot of expertise from commercial, marketing, and general management roles in various international corporations with him. He has worked with Pfizer, LVMH, Heineken, and Procter & Gamble in the United States and Brazil.
Companies are increasingly understanding the value that diversity and inclusion bring. Rodolfo’s appointment as Sanofi India’s new Managing Director positions the company to mobilise energy, boost agility, and meet the industry’s emerging challenges. His extensive global expertise, particularly in major emerging areas, will be extremely beneficial to the Company’s growth.
Aditya Narayan, Chairman of the Board, Sanofi India Limited “We are delighted to have Rodolfo Hrosz join Sanofi India as its Managing Director and look forward to his leading the team in the further development of the Company. His wide experience and diverse skills make him eminently suitable for this role and we wish him all the very best for every success in his new assignment.”
